ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Sören Alexander Weidemann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7037-3265; OpenAlex author ID A5065535588. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. Co-author DOI 10.1080/07357907.2021.1943747 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kristina Jansen · 1 shared paper, 2021 · strength 0.11
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
Till Krech · 1 shared paper, 2021 · strength 0.11
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
Till Sebastian Clauditz · 1 shared paper, 2021 · strength 0.11
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
Jakob Robert Izbicki · 1 shared paper, 2021 · strength 0.11
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.